The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy girls. Although the FDA approved testosterone therapy for the treatment of disorders involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study involved
about 800 older men with low testosterone and symptoms associated with this condition, such anti aging supplements for dogs
as sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
The recent contradictory findings on testosterone therapy prompted his team to conduct
a sizeable systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among guys and Patel. An estimated 13 million men in the United States suffer with low testosterone, which happens when the body does not make enough hormones as a result of a problem with the testicles or pituitary gland. This explains decline of energy, apparent aging and a person's unexpected weight gain.
No clear lower limit of testosterone has been established; yet 15 ng per dL (0.5 nmol per L) commonly is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had noticeably decreased sexual desire in all situations and absent or markedly decreased orgasms. Due to studies similar to this, supplemented with anecdotal evidence, many girls have been started on testosterone therapy. Most women can expect to spend one third of their lives in the postmenopausal stage. Depression, anger, moodiness, insomnia, and lack of well-being are common criticisms of postmenopausal women.